FAQ
Common questions about STERiJECT needles.
The design of STERiJECT needles, particularly the larger inner diameter and robust hub material, works in tandem to minimize patient discomfort. The smoother product flow enabled by the TSKiD™ barrels reduces the force required for injection, which can lead to less pain during the procedure. Additionally, the reliable connection and stability of the hard polymer hub ensure accurate delivery, further enhancing patient comfort during treatments.
The STERiJECT Needle is manufactured under stringent quality control standards to ensure safety and sterility. Each needle is individually packaged and sterilized, meeting international safety regulations. Practitioners can have confidence that each needle is ready for use in a sterile environment, minimizing the risk of infection during injections.
Yes. The STERiJECT Ophthalmic Needle is FDA 510(k) cleared for ophthalmic injections. It is also held to far stricter contamination limits than regular hypodermic needles: an endotoxin limit of 0.2 EU per device compared to the 20.0 EU allowed for regular needles, and compliance with the USP <789> particulate standard, which regular needles are not tested against. These controls matter for intravitreal injections, where even trace contaminants can pose a risk to the eye, and they give practitioners confidence that every needle meets the safety and quality standards required for ophthalmic procedures.
STERiJECT families are engineered around different clinical and delivery requirements. STERiJECT combines specialized technologies such as low-dead-space hubs, thin-wall cannulas, and advanced hub designs.
With small injection volumes, residual volume in the needle and hub can represent a meaningful portion of the intended dose. STERiJECT low-dead-space designs minimize the volume retained in the hub, supporting more accurate dose delivery and reducing product loss.
It depends on the procedure, formulation and performance requirements. VLDS uses a low-dead-space hub to reduce residual volume and support dose accuracy; VHPC uses extra-thin-wall technology to enlarge the internal diameter at the same gauge, for flow on viscous formulations; and VPRC pairs an extremely hard polymer hub with thin-wall technology, for higher-pressure and higher-viscosity injections.
Product samples may be available to qualified healthcare professionals and organizations for evaluation. Availability, quantity, pricing, shipping charges, documentation, and ordering requirements vary by product and region. After reviewing your request, our team will contact you to confirm the appropriate STERiJECT product and any applicable costs.